• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性肠易激综合征排便习惯的前瞻性评估:定义交替型。

A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.

作者信息

Drossman Douglas A, Morris Carolyn B, Hu Yuming, Toner Brenda B, Diamant Nicholas, Leserman Jane, Shetzline Michael, Dalton Christine, Bangdiwala Shrikant I

机构信息

UNC Center for Functional GI and Motility Disorders, University of North Carolina at Chapel Hill, Room 1110 Burnett-Womack CB#7080, Chapel Hill, North Carolina 27599-7080, USA.

出版信息

Gastroenterology. 2005 Mar;128(3):580-9. doi: 10.1053/j.gastro.2004.12.006.

DOI:10.1053/j.gastro.2004.12.006
PMID:15765393
Abstract

BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is subtyped as IBS with diarrhea (IBS-D) or IBS with constipation (IBS-C) based on Rome II guidelines. The remaining group is considered as having mixed IBS (IBS-M). There is no standard definition of an alternator (IBS-A), in which bowel habit changes over time. Our aim was to use Rome II criteria to prospectively assess change in bowel habit for more than 1 year to understand IBS-A.

METHODS

Female patients (n=317) with IBS entering a National Institutes of Health treatment trial were studied at baseline with questionnaires and 2-week daily diary cards of pain and stool frequency and consistency. Studies were repeated at the end of treatment (3 months) and at four 3-month intervals for one more year. Algorithms to classify subjects into IBS-D, IBS-C, and IBS-M groups used diary card information and modified Rome II definitions. Changes in bowel habit at 3-month intervals were then assessed using these surrogate diary card measures.

RESULTS

At baseline, 36% had IBS-D, 31% IBS-M, and 34% IBS-C. Except for stool frequency, there were no differences between groups. While the proportion of subjects in each subgroup remained the same over the year, most individuals (more than 75%) changed to either of the other 2 subtypes at least once. IBS-M was the least stable (50% changed out by 12 weeks). Patients were more likely to transition between IBS-M and IBS-C than between IBS-D and IBS-M. Notably, only 29% switched between the IBS-D and IBS-C subtypes over the year.

CONCLUSIONS

While the proportion of subjects in each of the IBS subtypes stays the same, individuals commonly transition between subtypes, particularly between IBS-M and IBS-C. We recommend that IBS-A be defined as at least one change between IBS-D and IBS-C by Rome II criteria over a 1-year period.

摘要

背景与目的

根据罗马II标准,肠易激综合征(IBS)分为腹泻型肠易激综合征(IBS-D)或便秘型肠易激综合征(IBS-C)。其余类型则被视为混合型肠易激综合征(IBS-M)。对于肠道习惯随时间变化的交替型肠易激综合征(IBS-A),目前尚无标准定义。我们的目的是使用罗马II标准对肠道习惯变化进行超过1年的前瞻性评估,以了解IBS-A。

方法

对317名参加美国国立卫生研究院治疗试验的IBS女性患者进行了研究,在基线时通过问卷调查以及疼痛、大便频率和大便稠度的2周每日记录卡进行调查。在治疗结束时(3个月)以及之后的一年中,每隔3个月重复进行研究。使用记录卡信息和修改后的罗马II定义,将受试者分类为IBS-D、IBS-C和IBS-M组的算法。然后使用这些替代记录卡测量方法评估每隔3个月的肠道习惯变化。

结果

在基线时,36%的患者为IBS-D,31%为IBS-M,34%为IBS-C。除大便频率外,各组之间无差异。虽然各亚组受试者的比例在一年中保持不变,但大多数个体(超过75%)至少有一次转变为其他两种亚型之一。IBS-M最不稳定(到12周时50%发生转变)。患者从IBS-M转变为IBS-C的可能性高于从IBS-D转变为IBS-M。值得注意的是,一年中只有29%的患者在IBS-D和IBS-C亚型之间转变。

结论

虽然IBS各亚型受试者的比例保持不变,但个体通常在各亚型之间转变,特别是在IBS-M和IBS-C之间。我们建议将IBS-A定义为根据罗马II标准在1年期间内IBS-D和IBS-C之间至少发生一次变化。

相似文献

1
A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.女性肠易激综合征排便习惯的前瞻性评估:定义交替型。
Gastroenterology. 2005 Mar;128(3):580-9. doi: 10.1053/j.gastro.2004.12.006.
2
Further characterization of painful constipation (PC): clinical features over one year and comparison with IBS.疼痛性便秘(PC)的进一步特征分析:一年的临床特征及与肠易激综合征的比较
J Clin Gastroenterol. 2008 Nov-Dec;42(10):1080-8. doi: 10.1097/mcg.0b013e31815146f9.
3
Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study).肠易激综合征患者肠道习惯随时间的变化:一项前瞻性观察性1年随访研究(RITMO研究)
Aliment Pharmacol Ther. 2007 Feb 1;25(3):323-32. doi: 10.1111/j.1365-2036.2006.03197.x. Epub 2007 Jan 8.
4
Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.罗马 III 标准下的肠易激综合征亚型:一项多中心研究。
J Gastroenterol Hepatol. 2012 Apr;27(4):760-5. doi: 10.1111/j.1440-1746.2011.06930.x.
5
Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar.根据罗马II和罗马III标准定义的肠易激综合征亚型相似。
J Clin Gastroenterol. 2009 Mar;43(3):214-20. doi: 10.1097/MCG.0b013e31815bd749.
6
Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification.肠易激综合征亚型的短期稳定性:采用 Rome III 分类的前瞻性评估。
Aliment Pharmacol Ther. 2012 Feb;35(3):350-9. doi: 10.1111/j.1365-2036.2011.04948.x. Epub 2011 Dec 18.
7
Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.根据主要排便习惯对肠易激综合征进行亚型分类:罗马II标准与罗马III标准对比
Aliment Pharmacol Ther. 2007 Sep 15;26(6):953-61. doi: 10.1111/j.1365-2036.2007.03422.x.
8
An examination of subgroup classification in irritable bowel syndrome patients over time: a prospective study.对肠易激综合征患者随时间变化的亚组分类进行的一项前瞻性研究。
Int J Nurs Stud. 2008 Dec;45(12):1715-20. doi: 10.1016/j.ijnurstu.2008.04.004. Epub 2008 Oct 1.
9
Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.用于评估临床试验中治疗效果的肠易激综合征症状日记的开发:基础定性研究。
Value Health. 2017 Apr;20(4):618-626. doi: 10.1016/j.jval.2016.11.001. Epub 2017 Jan 3.
10
Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.根据排便习惯划分的肠易激综合征亚型:重新审视交替型亚型。
Eur J Gastroenterol Hepatol. 2003 Feb;15(2):165-72. doi: 10.1097/00042737-200302000-00010.

引用本文的文献

1
Raising Expectations in IBS-C Management.提高IBS-C管理的期望。
Gastroenterol Hepatol (N Y). 2025 Apr;21(4):218-231.
2
Diagnostic Value of Fecal Lactoferrin in Differentiating Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Comparative Study in a Bangladeshi Cohort.粪便乳铁蛋白在鉴别炎症性肠病与肠易激综合征中的诊断价值:一项孟加拉队列的比较研究
Cureus. 2025 Apr 13;17(4):e82187. doi: 10.7759/cureus.82187. eCollection 2025 Apr.
3
Moving beyond Symptom Criteria to Diagnose and Treat Functional Disorders: Patient-Reported Symptoms of Functional Lower Gastrointestinal Disorders Correlate Poorly with Objective Assessment of Luminal Contents Seen on Intestinal Ultrasound.
超越症状标准以诊断和治疗功能性疾病:患者报告的功能性下消化道疾病症状与肠道超声所见管腔内容物的客观评估相关性较差。
J Clin Med. 2024 Aug 13;13(16):4759. doi: 10.3390/jcm13164759.
4
Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3).肠道通透性、便秘型肠易激综合征以及钠氢交换体3(NHE3)的作用
Clin Exp Gastroenterol. 2024 Jun 6;17:173-183. doi: 10.2147/CEG.S455101. eCollection 2024.
5
Rome IV Diagnostic Criteria for Functional Gastrointestinal Disorders in Patients with Chronic Hepatitis C Virus.丙型肝炎病毒慢性感染患者功能性胃肠病的罗马IV诊断标准
Middle East J Dig Dis. 2022 Apr;14(2):214-221. doi: 10.34172/mejdd.2022.275. Epub 2022 Apr 30.
6
Irritable bowel syndrome in adults: Prevalence and risk factors.成人肠易激综合征:患病率及危险因素
Ann Med Surg (Lond). 2022 Aug 19;81:104408. doi: 10.1016/j.amsu.2022.104408. eCollection 2022 Sep.
7
The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis.维生素 D 补充剂治疗肠易激综合征的疗效:系统评价与荟萃分析。
Nutr J. 2022 May 5;21(1):24. doi: 10.1186/s12937-022-00777-x.
8
Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.2020 年肠易激综合征循证临床实践指南。
J Gastroenterol. 2021 Mar;56(3):193-217. doi: 10.1007/s00535-020-01746-z. Epub 2021 Feb 4.
9
Stool frequency and form and gastrointestinal symptoms differ by day of the menstrual cycle in healthy adult women taking oral contraceptives: a prospective observational study.口服避孕药健康成年女性的粪便频率、形态和胃肠道症状随月经周期日而异:一项前瞻性观察研究。
BMC Womens Health. 2020 Jun 29;20(1):136. doi: 10.1186/s12905-020-01000-x.
10
New insights into irritable bowel syndrome: from pathophysiology to treatment.肠易激综合征的新见解:从病理生理学到治疗
Ann Gastroenterol. 2019 Nov-Dec;32(6):554-564. doi: 10.20524/aog.2019.0428. Epub 2019 Oct 22.